The Big Picture of IBD
An Interactive Experience Highlighting Recent Clinical Advances
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Colombel JF, et al. Lancet. 2018;390(10114):2779-2789.
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M, et al. Pharmacol Res. 2013;76:1-8.
Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies.
Kim DH, Cheon JH. Immune Netw. 2017;17(1):25-40.
The future of Janus kinase inhibitors in inflammatory bowel disease.
De Vries LCS, et al. J Crohns Colitis. 2017;11(7):885-893.
JAK inhibition in inflammatory bowel disease.
Olivera P, et al. Expert Rev Clin Immunol. 2017;13(7):693-703.
Tofacitinib as induction and maintenance therapy for ulcerative colitis.
Sandborn WJ, et al. N Engl J Med. 2017;377(5):496-497.
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
Vermeire S, et al. Lancet. 2017;389(10066):266-275.
Clinical Practice Guidelines
ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Lichtenstein GR, et al. Am J Gastroenterol. 2018;113(4):481-517.
Ulcerative Colitis Care Pathway.
Dassopoulos T, et al. Gastroenterology. 2015;149(1):238-45.
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Peyrin-Biroulet L, et al. Am J Gastroenterol. 2015;110(9):1324-1338.
European Crohn’s and Colitis Organisation guidelines
References for IBD management in Europe. The guidelines are updated regularly and available for download on the ECCO Website
Maasur C, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications.
J Crohns Colitis. 2018.
Sturm A, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.
J Crohns Colitis. 2018.
Patient Resources
Inflammatory Bowel Disease (IBD): What Is It?
Centers for Disease Control and Prevention (CDC)
Crohn’s and Colitis Foundation
Types of Medications for Crohn's Disease and Ulcerative Colitis
Treatment Decisions: Shared Decision Making
Advocacy Tools and Resources
Crohn’s Disease and Ulcerative Colitis: Emotional Factors Q & A
The National Institute of Diabetes and Digestive and Kidney Diseases Health Information
The Big Picture of IBD
An Interactive Experience Highlighting Recent Clinical Advances
| Faculty: | Stephen B. Hanauer, MD; Millie D. Long MD, MPH |
| Release: | 12/21/2018 |
| Expiration: | 12/21/2019 |
